EPITOPE Open-label Extension Study to Evaluate the Long-term Clinical Benefit and Safety of DBV712 in Peanut-Allergic Children
EPITOPE Open-label Extension Study to Evaluate the Long-term Clinical Benefit and Safety of DBV712 in Peanut-Allergic Children
Open-label, follow-up study for subjects who completed the EPITOPE study.
Inclusion Criteria:
Exclusion Criteria:
Los Angeles, California 90095, United States
Ann Arbor, Michigan 48106, United States